Deciphering hepatocellular carcinoma pathogenesis and therapeutics: a study on anoikis, ceRNA regulatory network and traditional Chinese medicine

被引:3
|
作者
Guo, Sa [1 ]
Xing, Nan [1 ]
Du, Qinyun [1 ]
Luo, Bin [2 ]
Wang, Shaohui [3 ,4 ]
机构
[1] Chengdu Univ Tradit Chinese Med, Sch Pharm, State Key Lab Southwestern Chinese Med Resources, Chengdu, Peoples R China
[2] Shanghai Univ Tradit Chinese Med, Shanghai Municipal Hosp Tradit Chinese Med, Shanghai, Peoples R China
[3] Chengdu Univ Tradit Chinese Med, Sch Ethn Med, State Key Lab Southwestern Chinese Med Resources, Chengdu, Peoples R China
[4] Chengdu Univ Tradit Chinese Med, Meishan Hosp, Meishan, Peoples R China
关键词
hepatocellular carcinoma; anoikis; prognostic signature; ceRNA; active compounds; BREAST-CANCER; CELL-CYCLE; RESISTANCE; PROLIFERATION; EXPRESSION; PREDICTION; APOPTOSIS; PATHWAY; ARREST;
D O I
10.3389/fphar.2023.1325992
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction: Hepatocellular carcinoma (HCC) is responsible for approximately 90% of liver malignancies and is the third most common cause of cancer-related mortality worldwide. However, the role of anoikis, a programmed cell death mechanism crucial for maintaining tissue equilibrium, is not yet fully understood in the context of HCC.Methods: Our study aimed to investigate the expression of 10 anoikis-related genes (ARGs) in HCC, including BIRC5, SFN, UBE2C, SPP1, E2F1, etc., and their significance in the disease.Results: Through Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses, we discovered that these ARGs are involved in important processes such as tissue homeostasis, ion transport, cell cycle regulation, and viral infection pathways. Furthermore, we found a significant correlation between the prognostic value of five ARGs and immune cell infiltrates. Analysis of clinical datasets revealed a strong association between BIRC5 expression and HCC pathological progression, including pathological stage, T stage, overall survival (OS), and race. By constructing a competing endogenous RNA (ceRNA) network and using molecular docking, we identified ten bioactive compounds from traditional Chinese medicine (TCM) that could potentially modulate BIRC5. Subsequent in vitro experiments confirmed the influence of platycodin D, one of the identified compounds, on key elements within the ceRNA network.Discussion: In conclusion, our study presents a novel framework for an anoikis-centered prognostic model and an immune-involved ceRNA network in HCC, revealing potential regulatory targets. These insights contribute to our understanding of HCC pathology and may lead to improved therapeutic interventions.
引用
收藏
页数:18
相关论文
共 50 条
  • [1] Construction of a ceRNA regulatory network to explore potential pathogenesis mechanisms involved in human hepatocellular carcinoma
    Yicun Liu
    Zhixing Dong
    WeiJie Chen
    Lin Chen
    Linling Ju
    Weihua Cai
    Xi Luo
    Zhaolian Bian
    Scientific Reports, 13
  • [2] Construction of a ceRNA regulatory network to explore potential pathogenesis mechanisms involved in human hepatocellular carcinoma
    Liu, Yicun
    Dong, Zhixing
    Chen, Weijie
    Chen, Lin
    Ju, Linling
    Cai, Weihua
    Luo, Xi
    Bian, Zhaolian
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [3] Traditional Chinese medicine as complementary treatment for hepatocellular carcinoma
    Jiao Kede
    Bie Limei
    Yin XiLing
    Yu Liqiu
    ETHIOPIAN JOURNAL OF HEALTH DEVELOPMENT, 2021, 35 (04)
  • [4] Elucidating the mechanism behind and investigating the efficacy of Traditional Chinese Medicine and Traditional Tibetan Medicine in combination with standard therapeutics in hepatocellular carcinoma and cholangiocarcinoma in vitro
    Suo, Huizhen
    Hochnadel, Inga
    Petriv, Nataliia
    Franke, Raimo
    Schmidt, Jennifer
    Limanska, Nataliia
    Tugai, Alisa
    Jedicke, Nils
    Broenstrup, Mark
    Manns, Michael P.
    Yevsa, Tetyana
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [5] Role of exosomes in hepatocellular carcinoma and the regulation of traditional Chinese medicine
    Yao, Man
    Liang, Shufang
    Cheng, Binbin
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [6] Alkaloids from Traditional Chinese Medicine against hepatocellular carcinoma
    Liu, Caiyan
    Yang, Shenshen
    Wang, Kailong
    Bao, Xiaomei
    Liu, Yiman
    Zhou, Shiyue
    Liu, Hongwei
    Qiu, Yuling
    Wang, Tao
    Yu, Haiyang
    BIOMEDICINE & PHARMACOTHERAPY, 2019, 120
  • [7] Role of traditional Chinese medicine in the management of patients with hepatocellular carcinoma
    Xi, Sheng-Yan
    Minuk, Gerald Yosel
    WORLD JOURNAL OF HEPATOLOGY, 2018, 10 (11) : 799 - 806
  • [8] Role of traditional Chinese medicine in the management of patients with hepatocellular carcinoma
    Sheng-Yan Xi
    Gerald Yosel Minuk
    World Journal of Hepatology, 2018, (11) : 799 - 806
  • [9] Impact of Traditional Chinese Medicine on Prognosis of Patients with Hepatocellular Carcinoma: A Retrospective Cohort Study
    Yuan, Huixin
    Niu, Qianqian
    Shang, Xiaofei
    Zhang, Liang
    Li, Li
    Yang, Huasheng
    Gou, Chunyan
    Li, Jingying
    Li, Hongyan
    Li, Xiuhui
    INTEGRATIVE CANCER THERAPIES, 2023, 22
  • [10] CERNA REGULATORY NETWORK REVEALS POTENTIAL PROGNOSTIC BIOMARKERS FOR OVERALL SURVIVAL IN HEPATOCELLULAR CARCINOMA
    Zhang, Zhiqiao
    Li, Jing
    He, Tingshan
    Ouyang, Yanling
    Huang, Yiyan
    Liu, Qingbo
    Wang, Peng
    Ding, Jianqiang
    HEPATOLOGY, 2019, 70 : 224A - 224A